- Home
- BHB vs ATXS Comparison
BHB vs ATXS Comparison
Compare BHB & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHB
- ATXS
- Stock Information
- Founded
- BHB 1887
- ATXS 2008
- Country
- BHB United States
- ATXS United States
- Employees
- BHB N/A
- ATXS N/A
- Industry
- BHB Major Banks
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- BHB Finance
- ATXS Health Care
- Exchange
- BHB Nasdaq
- ATXS Nasdaq
- Market Cap
- BHB 456.0M
- ATXS 401.2M
- IPO Year
- BHB 1997
- ATXS 2015
- Fundamental
- Price
- BHB $29.31
- ATXS $5.65
- Analyst Decision
- BHB Hold
- ATXS Strong Buy
- Analyst Count
- BHB 2
- ATXS 7
- Target Price
- BHB $33.00
- ATXS $32.43
- AVG Volume (30 Days)
- BHB 40.4K
- ATXS 393.7K
- Earning Date
- BHB 07-17-2025
- ATXS 08-11-2025
- Dividend Yield
- BHB 4.33%
- ATXS N/A
- EPS Growth
- BHB 3.26
- ATXS N/A
- EPS
- BHB 2.84
- ATXS N/A
- Revenue
- BHB $149,882,000.00
- ATXS N/A
- Revenue This Year
- BHB $18.22
- ATXS N/A
- Revenue Next Year
- BHB $13.38
- ATXS N/A
- P/E Ratio
- BHB $10.41
- ATXS N/A
- Revenue Growth
- BHB 2.29
- ATXS N/A
- 52 Week Low
- BHB $24.65
- ATXS $3.56
- 52 Week High
- BHB $38.47
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- BHB 50.90
- ATXS 56.50
- Support Level
- BHB $28.39
- ATXS $5.41
- Resistance Level
- BHB $30.13
- ATXS $6.13
- Average True Range (ATR)
- BHB 0.64
- ATXS 0.43
- MACD
- BHB 0.05
- ATXS -0.01
- Stochastic Oscillator
- BHB 59.41
- ATXS 53.76
About BHB Bar Harbor Bankshares Inc.
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.